Safety and efficacy of oral potassium iodide in chromoblastomycosis.
Narendranath
S
S
Sudhakar
G K
GK
Pai
Mirabel R S M
MR
Kini
Hema
H
Pinto
Jerome
J
Pai
Mirabel R S M
MR
D000368:Aged; D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use; D002862:Chromoblastomycosis / Q000188:drug therapy* / Q000473:pathology; D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D009281:Naphthalenes / Q000191:economics / Q000627:therapeutic use; D011193:Potassium Iodide / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D011193:Potassium Iodide; D000077291:Terbinafine